|
IPP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.222760E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.619300E-03 |
| Normal-vs-Stage2 |
2.448000E-02 |
| Normal-vs-Stage3 |
4.365100E-04 |
| Normal-vs-Stage4 |
2.418300E-04 |
| Stage1-vs-Stage2 |
8.482800E-01 |
| Stage1-vs-Stage3 |
1.848580E-01 |
| Stage1-vs-Stage4 |
8.982300E-02 |
| Stage2-vs-Stage3 |
4.680200E-01 |
| Stage2-vs-Stage4 |
3.112600E-01 |
| Stage3-vs-Stage4 |
6.758200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.217970E-03 |
| Normal-vs-AfricanAmerican |
2.153400E-01 |
| Normal-vs-Asian |
5.398800E-03 |
| Caucasian-vs-AfricanAmerican |
3.329400E-01 |
| Caucasian-vs-Asian |
7.967400E-01 |
| AfricanAmerican-vs-Asian |
2.956000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.186550E-04 |
| Normal-vs-Female |
4.859700E-03 |
| Male-vs-Female |
1.306370E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.041900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.121540E-03 |
| Normal-vs-Age(61-80Yrs) |
9.639200E-04 |
| Normal-vs-Age(81-100Yrs) |
1.315740E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.963200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.220000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.249000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.988200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.324000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.113800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.919500E-03 |
| Classical-VS-Follicular |
3.615600E-02 |
| Classical-VS-Other |
1.070820E-01 |
| Classical-VS-Normal |
2.168000E-02 |
| Tall-VS-Follicular |
3.379800E-01 |
| Tall-VS-Other |
5.424400E-01 |
| Tall-VS-Normal |
4.0735000000014E-05 |
| Follicular-VS-Other |
3.919600E-01 |
| Follicular-VS-Normal |
7.774700E-04 |
| Other-VS-Normal |
1.016240E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.618500E-03 |
| Normal-vs-N1 |
9.017100E-04 |
| N0-vs-N1 |
3.181600E-01 |
|
|
